James Ritchie

Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Steven A. Carr, Susan E. Abbatiello, Bradley L. Ackermann et al. · Molecular & Cellular Proteomics · 2014 · 550 citations · Full text

Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress

PB Chappell, M. T. Smith, CD Kilts et al. · Journal of Neuroscience · 1986 · 466 citations · Full text

Unpredictable Stressors, Corticotropin-releasing Factor-like Immunoreactivity, Crf-like Immunoreactivity +23

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer

R. Ayesh, Jeffrey R. Idle, James Ritchie et al. · Nature · 1984 · 383 citations

Biochemistry, Oncogenic Agent, Medicine +10

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice

Daniel F. Manvich, Kevin A. Webster, Stephanie L. Foster et al. · Scientific Reports · 2018 · 370 citations · Full text

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

Stuart Watson, Peter Gallagher, James Ritchie et al. · The British Journal of Psychiatry · 2004 · 344 citations · Full text